Marcus Bronzel

PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with ¹⁷⁷Lu-Labeled PSMA-617

Clemens Kratochwil, Frederik L. Giesel, M. Stefanova et al. · Journal of Nuclear Medicine · 2016 · 621 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke et al. · Journal of Nuclear Medicine · 2017 · 496 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

Igor D. Grachev, Philipp Meyer, Georg Becker et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 50 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Dosimetry Estimate and Initial Clinical Experience with ⁹⁰Y-PSMA-617

Hendrik Rathke, Paul Flechsig, Walter Mier et al. · Journal of Nuclear Medicine · 2018 · 44 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls

Ralph Buchert, Andreas Kluge, Livia Tossici-Bolt et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 36 citations · Full text

Medicine, Biostatistics, Biomedical Imaging +11